Before delinking, pharmacy benefit managers were able to tie their fees to significantly high-priced medications, in turn receiving large percentages of compensation rather than flat, fixed fees.
Paul Silverman
Advertisement
Articles by Paul Silverman
Advertisement
Latest Updated Articles
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025Published: October 24th 2025 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
What TrumpRx Means for Independent Pharmacies and Their Patients
2
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
3
As Pharmacists Enter More Clinical Roles, So Do Pharmacy Technicians | ASHP Midyear 2025
4
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
5
